Clinical trial
Examination of Glutamate and mGluR5 in Psychiatric Disorders
NCT02727972 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Examination of Glutamate and mGluR5 in Psychiatric Disorders
- Lead sponsor
- Yale University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 21, 2012
- Completion date
- January 13, 2022
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder, major depressive disorder, post-traumatic stress disorder